JCB logo
Quantitative Colocalization Analysis Software
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 6 December 2004. doi:10.1083/jcb.200404149
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 167, Number 5, 953-960
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1867K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abad-Rodriguez, J.
Right arrow Articles by Dotti, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abad-Rodriguez, J.
Right arrow Articles by Dotti, C. G.
Related Collections
Right arrowRelated Article
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Article

Neuronal membrane cholesterol loss enhances amyloid peptide generation



Jose Abad-Rodriguez1, Maria Dolores Ledesma1, Katleen Craessaerts2, Simona Perga1, Miguel Medina1, Andre Delacourte3, Colin Dingwall4, Bart De Strooper2, and Carlos G. Dotti1

1 Cavalieri Ottolenghi Scientific Institute, Universita degli Studi di Torino, 10043 Orbassano (TO), Italy
2 Center for Human Genetics, Catholic University of Leuven and Flanders Interuniversitary Institute for Biotechnology, 3000 Leuven, Belgium
3 Unité INSERM 422, Lille, France
4 Neurology and GI CEDD, GlaxoSmithKline Pharmaceuticals, Harlow, Essex CM195AW, England, UK

Correspondence to Carlos G. Dotti: carlos.dotti{at}unito.it; or Bart De Strooper: Bart.Destrooper{at}med.kuleuven.ac.be

Recent experimental and clinical retrospective studies support the view that reduction of brain cholesterol protects against Alzheimer's disease (AD). However, genetic and pharmacological evidence indicates that low brain cholesterol leads to neurodegeneration. This apparent contradiction prompted us to analyze the role of neuronal cholesterol in amyloid peptide generation in experimental systems that closely resemble physiological and pathological situations. We show that, in the hippocampus of control human and transgenic mice, only a small pool of endogenous APP and its ß-secretase, BACE 1, are found in the same membrane environment. Much higher levels of BACE 1–APP colocalization is found in hippocampal membranes from AD patients or in rodent hippocampal neurons with a moderate reduction of membrane cholesterol. Their increased colocalization is associated with elevated production of amyloid peptide. These results suggest that loss of neuronal membrane cholesterol contributes to excessive amyloidogenesis in AD and pave the way for the identification of the cause of cholesterol loss and for the development of specific therapeutic strategies.

J. Abad-Rodriguez and M.D. Ledesma contributed equally to this work.

Abbreviations used in this paper: Aß, amyloid peptide; AD, Alzheimer's disease; ß-CTF, ß-COOH-terminal fragment; CNS, central nervous system; DRM, detergent-resistant membrane; MCD, methyl-ß-cyclodextrin; SFV-APP, Semliki Forest virus/human APP.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Cholesterol prevents Alzheimer's
Nicole LeBrasseur
J. Cell Biol. 2004 167: 805. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents